FDA approves Radius Health's osteoporosis drug Tymlos

(Reuters) - The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.